Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Sinovac Varicella Vaccine in Healthy Children
NCT02981836Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Aug 2016
- Primary completion
- Jun 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of varicella vaccine live in varicella (VZV) (2 arms), sponsored by Sinovac Biotech Ltd. Primary endpoints: The incidences of varicella of each group and The protection rate of the vaccine. Started Aug 2016; status: completed.
02
Drugs
varicella vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT02981836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981836.